cervical high-risk human papilloma virus infection
Conditions
Interventions
Treatment group:Use the patch during the non-menstrual period, paste the "far infrared acupoint paste" on the outside of Qugu acupoint underwear after taking a bath every night after menstruation is c
Control group:Use the patch during the non-menstrual period, paste the "comfort paste" on the outside of Qugu acupoint underwear after taking a bath every night after menstruation is clean, and change
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Patients with cervical HR-HPV infection. 2) Patients with pathologically diagnosed CIN grade I or less (including LSIL, mucosal inflammation, SPI, etc.). 3) Female patients aged between 21 and 65 with regular menstruation or menopause and sexual history. 4) Women whose body mass index (Body Mass Index,BMI) is within the normal range (18.5 = BMI < 24.0 kg/m2). 5) Patients did not participate in the clinical trial of other acupoints in the past 1 month, and did not use a patch similar to that of the experimental acupoint. 6) Patients who have no fertility requirements in the past half a year. 7) Patients who are willing to cooperate with the treatment follow-up and sign the informed consent form. 8) Researchers believe that patients are suitable to participate in clinical trials. 9) Patients without major organ diseases.
Exclusion criteria
Exclusion criteria: 1) Patients with acute infection of external genitalia, including candidal vaginitis, trichomonal vaginitis, chlamydia trachomatis infection and acute pelvic inflammatory disease. 2) Vaginal cleanliness IV degree. 3) lactating women and pregnant women. 4) Patients with systemic chronic consumptive diseases, severe cardiovascular diseases, liver and kidney diseases, and hematopoietic system diseases. 5) Patients with mental illness. 6) Patients who have a history of immune system and are using immunosuppressants. 7) Patients with a history of allergy or allergy to acupoint sticking.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HPV negative conversion rate;Pathological reversal rate;Changes of vaginal lavage fluid indexes (IL-2);Changes of vaginal lavage fluid indexes (IL-10);Changes of vaginal lavage fluid indexes (TNF- a); | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of clinical symptoms; | — |
Countries
China
Contacts
Public ContactJing Xiao
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed